Among preventive strategies against dementia, nutrition is considered a powerful one and the recently established “nutritional cognitive neuroscience of aging” is a highly active research field.
Objective:
The present study was designed to deeply characterize older adults across the continuum from cognitive integrity to mild cognitive impairment (MCI) and better elucidate the prognostic role of lipophilic micronutrients within their lipidomic signature.
Methods:
123 participants older than 65 years across the continuum from cognitive integrity to MCI were included [49 with subjective cognitive impairment, 29 women, 72.5±5.4 years, 26 MCI, 9 women, 74.5±5.8 years and 50 without cognitive impairment, 21 women, 70.8±4.3 years]. All participants underwent neuropsychological and nutritional examination as well as comprehensive geriatric assessment with calculation of the Multidimensional Prognostic Index (MPI) as a proxy of frailty and biological age and blood withdrawal for the analyses of lipophilic micronutrients, metabolomics and oxylipidomics. One year after the evaluation, same tests are ongoing.
Results:
After adjustment for age, sex, daily fruit and vegetable intake and cholesterol, we found a significant positive correlation between lutein and the number of correct words in category fluency (p = 0.016).
Conclusions:
This result supports the importance of carotenoids as robust biomarkers of cognitive performance independent of the nutritional status and frailty of the participants, as the entire present study collective was robust (MPI 0–0.33). The complete analyses of the metabolome and the oxylipidome will hopefully shed light on the metabolic and prognostic signature of cognitive decline in the rapidly growing population at risk of frailty.
St SauverJL, BoydCM, GrossardtBR, et al. Risk of developing multimorbidity across all ages in an historical cohort study: Differences by sex and ethnicity. BMJ Open2015; 5: e006413.
WannerC, InzucchiSE and ZinmanB. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med2016; 375: 1801–1802.
4.
MosenzonO, BlicherTM, RosenlundS, et al. Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): A placebo-controlled, randomised, phase 3a trial. Lancet Diabetes Endocrinol2019; 7: 515–527.
5.
Budd HaeberleinS, AisenPS, BarkhofF, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer’s disease. J Prev Alzheimers Dis2022; 9: 197–210.
6.
SwansonCJ, ZhangY, DhaddaS, et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Abeta protofibril antibody. Alzheimers Res Ther2021; 13: 80.
7.
PolidoriMC, NellesG and PientkaL. Prevention of dementia: Focus on lifestyle. Int J Alzheimers Dis2010; 2010: 393579.
8.
TownsendRF, LoganD, O’NeillRF, et al. Whole dietary patterns, cognitive decline and cognitive disorders: A systematic review of prospective and intervention studies. Nutrients2023; 15: 333.
9.
MamalakiE, CharisisS, AnastasiouCA, et al. The longitudinal association of lifestyle with cognitive health and dementia risk: Findings from the HELIAD Study. Nutrients2022; 14: 2818.
10.
PolidoriMC. Physiology of aging as a basis of complexity in aging medicine and geriatrics. In GuD and DupreME (eds) Encyclopedia of Biogerontology and Population Aging. Cham: Springer, 2020.
11.
HornburgD, WuS, MoqriM, et al. Dynamic lipidome alterations associated with human health, disease and ageing. Nat Metab2023; 5: 1578–1594.
12.
PolidoriMC, StahlW and GriffithsHR. Nutritional cognitive neuroscience of aging: Focus on carotenoids and cognitive frailty. Redox Biol2021; 44: 101996.
13.
RattanSIS and KaurG. Nutrition, food and diet in health and longevity: We eat what we are. Nutrients2022; 14: 5376.
14.
GergerP, PaiRK, StuckenschneiderT, et al. Associations of lipophilic micronutrients with physical and cognitive fitness in persons with mild cognitive impairment. Nutrients2019; 11: 902.
15.
Lorenzo-LopezL, MasedaA, de LabraC, et al. Nutritional determinants of frailty in older adults: A systematic review. BMC Geriatr2017; 17: 108.
16.
PolidoriMC, CarrilloJC, VerdePE, et al. Plasma micronutrient status is improved after a 3-month dietary intervention with 5 daily portions of fruits and vegetables: Implications for optimal antioxidant levels. Nutr J2009; 8: 10.
17.
RietmanML, SpijkermanAMW, WongA, et al. Antioxidants linked with physical, cognitive and psychological frailty: Analysis of candidate biomarkers and markers derived from the MARK-AGE study. Mech Ageing Dev2019; 177: 135–143.
18.
RinaldiP, PolidoriMC, MetastasioA, et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging2003; 24: 915–919.
19.
SiesH, BelousovVV, ChandelNS, et al. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat Rev Mol Cell Biol2022; 23: 499–515.
20.
KaoYC, HoPC, TuYK, et al. Lipids and Alzheimer’s disease. Int J Mol Sci2020; 21: 1505.
21.
DiasIHK, MilicI, HeissC, et al. Inflammation, lipid (per)oxidation, and redox regulation. Antioxid Redox Signal2020; 33: 166–190.
22.
DiasIHK, MilicI, LipGYH, et al. Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia. Redox Biol2018; 16: 139–145.
23.
DiasHK, BrownCL, PolidoriMC, et al. LDL-lipids from patients with hypercholesterolaemia and Alzheimer’s disease are inflammatory to microvascular endothelial cells: Mitigation by statin intervention. Clin Sci (Lond)2015; 129: 1195–1206.
24.
DiasIH, PolidoriMC, LiL, et al. Plasma levels of HDL and carotenoids are lower in dementia patients with vascular comorbidities. J Alzheimers Dis2014; 40: 399–408.
25.
PolidoriMC. Embracing complexity of (brain) aging. FEBS Lett2024; doi: 10.1002/1873-3468.14941.
26.
RabinLA, SmartCM, CranePK, et al. Subjective cognitive decline in older adults: An overview of self-report measures used across 19 international research studies. J Alzheimers Dis2015; 48(Suppl 1): S63–S86.
27.
JessenF, AmariglioRE, van BoxtelM, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement2014; 10: 844–852.
28.
NasreddineZS, PhillipsNA, BedirianV, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc2005; 53: 695–699.
29.
StuckenschneiderT, SandersML, DevenneyKE, et al. NeuroExercise: The effect of a 12-month exercise intervention on cognition in mild cognitive impairment-a multicenter randomized controlled trial. Front Aging Neurosci2020; 12: 621947.
30.
CellaA, FerrariA, RengoG, et al. Agreement of a short form of the Self-Administered Multidimensional Prognostic Index (SELFY-MPI-SF): A useful tool for the self-assessment of frailty in community-dwelling older people. Clin Interv Aging2020; 15: 493–499.
31.
TombaughTN. Trail Making Test A and B: Normative data stratified by age and education. Arch Clin Neuropsychol2004; 19: 203–214.
32.
ReitanRM. The relation of the trail making test to organic brain damage. J Consult Psychol1955; 19: 393–394.
33.
RubensteinLZ, StuckAE, SiuAL, et al. Impacts of geriatric evaluation and management programs on defined outcomes: Overview of the evidence. J Am Geriatr Soc1991; 39: 8S–16S; discussion 17S–18S.
34.
PilottoA, SancarloD, PanzaF, et al. The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia. J Alzheimers Dis2009; 18: 191–199.
35.
SalviF, MillerMD, GrilliA, et al. A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc2008; 56: 1926–1931.
36.
RubensteinLZ, HarkerJO, SalvaA, et al. Screening for undernutrition in geriatric practice: Developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci2001; 56: M366–372.
37.
KatzS, FordAB, MoskowitzRW, et al. Studies of Illness in the Aged. The Index of ADL: A standardized measure of biological and psychosocial function. JAMA1963; 185: 914–919.
38.
LawtonMP and BrodyEM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist1969; 9: 179–186.
39.
BlissMR, McLarenR and Exton-SmithAN. Mattresses for preventing pressure sores in geriatric patients. Mon Bull Minist Health Public Health Lab Serv1966; 25: 238–268.
40.
PfeifferE. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc1975; 23: 433–441.
ChuAH, NgSH, KohD, et al. Reliability and Validity of the Self- and Interviewer-Administered Versions of the Global Physical Activity Questionnaire (GPAQ). PLoS One2015; 10: e0136944.
43.
LudwigK, Graf von der SchulenburgJM and GreinerW. German value set for the EQ-5D-5L. Pharmacoeconomics2018; 36: 663–674.
WeigertH, StuckenschneiderT, PickertL, et al. Influence of a 12-month structured exercise program on the micronutrient-cognitive fitness-physical association profiles in mild cognitive impairment. J Alzheimers Dis Rep2022; 6: 711–722.
46.
Scheidt-NaveC, KamtsiurisP, GosswaldA, et al. German health interview and examination survey for adults (DEGS) – design, objectives and implementation of the first data collection wave. BMC Public Health2012; 12: 730.
47.
AustO, SiesH, StahlW, et al. Analysis of lipophilic antioxidants in human serum and tissues: Tocopherols and carotenoids. J Chromatogr A2001; 936: 83–93.
48.
BohmV, LietzG, Olmedilla-AlonsoB, et al. From carotenoid intake to carotenoid blood and tissue concentrations – implications for dietary intake recommendations. Nutr Rev2021; 79: 544–573.
49.
StuetzW, WeberD, DolleME, et al. Plasma carotenoids, tocopherols, and retinol in the age–stratified (35–74 years) general population: A cross-sectional study in six European countries. Nutrients2016; 8: 614.
50.
PolidoriMC, PraticoD, MangialascheF, et al. High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. J Alzheimers Dis2009; 17: 921–927.
51.
McDonnellM, DillL, PanosS, et al. Verbal fluency as a screening tool for mild cognitive impairment. Int Psychogeriatr2020; 32: 1055–1062.
52.
PolidoriMC, StahlW, De SpirtS, et al. Influence of vascular comorbidities on the antioxidant defense system in Alzheimer’s disease. Dtsch Med Wochenschr2012; 137: 305–308.
53.
MangialascheF, BaglioniM, CecchettiR, et al. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer’s disease and mild cognitive impairment. J Alzheimers Dis2015; 44: 649–660.
54.
FranceschiC, GaragnaniP, PariniP, et al. Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol2018; 14: 576–590.
55.
MorrisLJ, D’EsteC, Sargent-CoxK, et al. Concurrent lifestyle risk factors: Clusters and determinants in an Australian sample. Prev Med2016; 84: 1–5.
56.
LawderR, HardingO, StocktonD, et al. Is the Scottish population living dangerously? Prevalence of multiple risk factors: The Scottish Health Survey 2003. BMC Public Health2010; 10: 330.
57.
FalkenreckJM, KunklerMC, OpheyA, et al. Effects of the multicomponent cognitive training program BrainProtect in cognitively healthy adults: A randomized controlled trial. J Alzheimers Dis2023; 94: 1013–1034.
